Experimental studies in genetically modified mice and diet-induced NAFLD suggest that alterations in GNMT, MAT1A, and ACHY expression can contribute to NASH development in humans [72, 80, 87]. This evidence concerns the gene GNMT and metabolic dysfunction-associated steatotic liver disease.